Description
KPV is the C-terminal alpha-MSH tripeptide that suppresses NF-kB transcriptional activity through receptor-independent intracellular IkBa stabilization and p65 nuclear translocation inhibition. KPV capsules are particularly well-suited among peptide research compounds because of their documented PepT1 di/tripeptide transporter-mediated intestinal epithelial uptake, making oral delivery a biologically relevant experimental condition rather than simply a handling convenience. Researchers studying NF-kB suppression in gastrointestinal epithelial models use the capsule format to leverage this transporter-specific oral uptake mechanism.
Storage and Handling
Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. Refer to the lot-specific certificate of analysis for recommended storage conditions.
Compliance Notice
KPV capsules are for laboratory research use only. They are not for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.
